April 02, 2025 10:24 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
In a major boost for tourism, Shimla to get Asia's longest ropeway spanning 13.79 kilometers | Karnataka govt hikes sales tax on diesel, price goes up by Rs. 2 | 'Heard India will be dropping its tariffs substantially': Donald Trump ahead of announcing reciprocal tariff | Opposition MPs decide to vote against Waqf Amendment Bill in Parliament tomorrow | Chilean President Boric visits India, discusses ways to expand bilateral ties with Modi | Himanta Biswa Sarma slams Muhammad Yunus' Northeast remarks, Tripura leader suggests Bangladesh's split | Modi govt determined to uproot Naxalism by March 31, 2026: Amit Shah | Time for reciprocity: White House refers to India's 100 percent tariff imposed on US agri products ahead of April 2 deadline | Fresh encounter breaks out in J&K's Kathua, security forces trap 3 terrorists | Pakistani advocacy group nominates Imran Khan for Nobel Peace Prize

AstraZeneca's COVID-19 vaccine trial to resume in US

Oct 24, 2020, at 03:28 pm

Washington/Xinhua: Multinational pharmaceutical company AstraZeneca said on Friday it will resume the trial of its experimental COVID-19 vaccine in the United States, which has been paused since September.

WHO on Johnson&Johnson halting COVID vaccine trial: Safety paramount

Oct 13, 2020, at 09:16 pm

Moscow/Sputnik: The World Health Organization believes that safety in research is crucial and is pleased to see developers acting by the rules, the WHO spokesperson told Sputnik regarding Johnson&Johnson suspending its vaccine trials.

After Oxford Covid-19 Vaccine trial pause, DCGI sends show-cause notice to Serum Institute

Sep 10, 2020, at 04:23 am

New Delhi/IBNS: After pharmaceutical giant AstraZeneca halted the Phase 3 study testing of the Oxford Vaccine against Covid-19, the Drugs Controller General of India (DCGI) on Wednesday issued a show-cause notice to Serum Institute of India (SII) for not informing the central drug regulator about the pause of trials in other countries.

AstraZeneca pauses Covid-19 vaccine trial after suspected adverse reaction seen in participant

Sep 09, 2020, at 01:30 pm

London:  Pharmaceutical company AstraZeneca has halted the Phase 3 study testing of a Covid-19 vaccine after a suspected serious adverse reaction was seen in a participant in the United Kingdom, media reports said.

Close menu